Jan 27, 2017 by Brian FeroldiWhy Novan Inc. Is Imploding TodayShares collapsed after the company released disappointing results in one of its two phase 3 clinical trials.
Jan 26, 2017 by Brian Feroldi3 Reasons Intuitive Surgical, Inc. Stock Could FallThe robotic surgery pioneer may be well positioned for success, but there are still risks.
Jan 25, 2017 by Brian FeroldiRising Energy Prices Allow Cullen/Frost Bankers' Profits to SoarA strong recovery in the energy sector causes the regional bank's profits to bounce back.
Jan 25, 2017 by Brian FeroldiWhy Horizon Global Is Falling TodayShares drop after management provided investors with a preliminary look at full-year 2016 results that failed to impress.
Jan 25, 2017 by Brian FeroldiResMed's Revenue Jumps, but Higher Costs Keep Profits in CheckNew product launches and acquisitions lead to double-digit growth in sales, but higher spending caused profits to flatline.
Jan 24, 2017 by Brian FeroldiWhy ResMed Is in the Green TodayShares jump in response to a better-than-expected earnings report.
Jan 23, 2017 by Brian FeroldiWhy Cynosure, Inc. Is Rising TodayRumors that the company could be an acquisition target caused shares to spike on Monday.
Jan 23, 2017 by Brian Feroldi3 Reasons Intuitive Surgical, Inc. Stock Could RiseIntuitive Surgical's investors have many reasons to be excited about its future.
Jan 22, 2017 by Brian FeroldiTop Biotech Stocks to Buy in 2017These three biotech stocks look poised to outperform.
Jan 20, 2017 by Brian FeroldiSkyworks Solutions Inc. Beats Its Guidance and Issues a Bullish OutlookSkyworks' expanding customer base allowed it to post revenue and profits that came in ahead of management's projections.
Jan 20, 2017 by Brian Feroldi3 Key Metrics for Infinera's Investors to Focus OnHere are the three key areas that I'll be watching in 2017.
Jan 19, 2017 by Brian FeroldiHere's Why CoLucid Pharmaceuticals Inc Popped YesterdayShares skyrocket in response to accepting a takeover offer from Eli Lilly.
Jan 19, 2017 by Brian FeroldiWhy Zynerba Pharmaceuticals Inc. Is Tanking TodayShares dropped after disappointing pricing details were released from the company's secondary common stock offering.
Jan 18, 2017 by Brian Feroldi3 Reasons CVS Health Corporation Stock Could RiseThe bull case for owning CVS Health's shares continues to look strong.
Jan 17, 2017 by Brian Feroldi5 Highest-Dividend-Yielding StocksThese five stocks offer up huge yields, but are any of them actually worth owning?
Jan 16, 2017 by Brian FeroldiDoes Johnson & Johnson Pass the Buffett Test?Does the healthcare conglomerate pass Warren Buffett's acquisition test?
Jan 16, 2017 by Brian Feroldi, Dan Caplinger, and Steve Symington3 Stocks the Market Loves to Hate but That You Should LoveThe markets may loathe Nordstrom, CVS Health, and Chipotle right now, but our team of Fools thinks all three are compelling buys.
Jan 15, 2017 by Brian FeroldiTop Consumer Stocks to Buy in 2017Here's why Chipotle Mexican Grill, Duluth Holdings, and Casey's General Stores all look like strong buys right now.
Jan 15, 2017 by Brian FeroldiThe 10 Best Stocks in the Nasdaq in 2016Here's why these 10 companies turned out to be home run investments last year.
Jan 14, 2017 by Brian FeroldiThe Worst Retail Stocks of 2016Here's a closer look at why GNC Holdings, Noodles & Co., and Restoration Hardware were all horrific performers last year.
